Fluorocyclopentenylcytosine Uses, Dosage, Side Effects and more
Fluorocyclopentenylcytosine is under investigation in clinical trial NCT03189914 (RX-3117 in Combination With Abraxane® in Subjects With Metastatic Pancreatic Cancer).
| Trade Name | Fluorocyclopentenylcytosine |
| Generic | Fluorocyclopentenylcytosine |
| Fluorocyclopentenylcytosine Other Names | Fluorocyclopentenylcytosine, Roducitabine |
| Type | |
| Formula | C10H12FN3O4 |
| Weight | Average: 257.221 Monoisotopic: 257.081184041 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
